<生产厂家价格>

克拉维酸

克拉维酸用途

克拉维酸是一种天然存在的强大细菌β-内酰胺酶抑制剂,用于研究细菌引起的感染,包括耳朵感染。克拉维酸对广谱革兰氏阳性和革兰氏阴性细菌具有活性【1】。

克拉维酸名称

[ CAS 号 ]:
58001-44-8

[ 中文名 ]:
克拉维酸

[ 英文名 ]:
Clavulanate

[中文别名 ]:

[英文别名 ]:

Acide clavulanique
Acid clavulanico
acidum clavulanicum
Clavulansaeure
EINECS 261-069-2
CLAVULANIC ACID
Clavulanate
Sodium Clavulanate

克拉维酸生物活性

[ 描述 ]:

[ 相关类别 ]:

研究领域 >> 感染

研究领域 >> 炎症/免疫

信号通路 >> 抗感染 >> 细菌

[参考文献]

[1]. Parag S Saudagar, et al. Clavulanic acid: a review. Biotechnol Adv. Jul-Aug 2008;26(4):335-51

克拉维酸物理化学性质

[ 密度 ]:
1.7±0.1 g/cm3

[ 沸点 ]:
545.8±50.0 °C at 760 mmHg

[ 分子式 ]:
C₈H₉NO₅

[ 分子量 ]:
199.16

[ 闪点 ]:
283.9±30.1 °C

[ 精确质量 ]:
199.048065

[ PSA ]:
87.07000

[ LogP ]:
-1.98

[ 外观性状 ]:
白色至灰白色粉末

[ 蒸汽压 ]:
0.0±3.3 mmHg at 25°C

[ 折射率 ]:
1.644

[ 储存条件 ]:
常温

克拉维酸毒性和生态

CHEMICAL IDENTIFICATION

RTECS NUMBER :: RN6802500

CHEMICAL NAME :: 4-Oxa-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3-(2-hydroxyethylidene)-7-oxo-, (2R-(2-alpha,3Z,5-alpha))-

CAS REGISTRY NUMBER :: 58001-44-8

LAST UPDATED :: 199612

DATA ITEMS CITED :: 7

MOLECULAR FORMULA :: C8-H9-N-O5

MOLECULAR WEIGHT :: 199.18

WISWESSER LINE NOTATION :: T45 ANV EOYTJ FU2Q GVQ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 7936 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 16,590,1985

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 1399 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 16,590,1985

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 1393 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 16,590,1985

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 4526 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 16,590,1985

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 1531 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 16,590,1985

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 2185 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 16,590,1985

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 4 gm/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: 85GDA2 "CRC Handbook of Antibiotic Compounds," Vols.1- , Berdy, J., Boca Raton, FL, CRC Press, 1980- Volume(issue)/page/year: 4(1),129,1980

克拉维酸安全信息

[ 危害码 (欧洲) ]:
Xi

[ 海关编码 ]:
2934995000

克拉维酸合成路线

详细合成路线

克拉维酸上下游产品

克拉维酸上游产品

克拉维酸下游产品

克拉维酸制备

方法1：微生物合成，以黄豆粉、葡萄糖、淀粉或糊精为原料，经发酵而成。
方法2：以3-甲硫基丙内酰胺为原料，经烷化、氯化脱羧等步骤反应合成。

克拉维酸海关

[ 海关编码 ]: 2934995000

克拉维酸相关知识

克拉维酸_临床应用_不良反应_药物相作用

2022-05-23 18:27:01

克拉维酸（Clavulanate Potassium），商品名棒酸钾。其为氧青霉烷类β-内酰胺酶抑制剂，是由β-内酰胺环和氢化异噁唑环骈合而成的，是一种自杀性的酶抑制剂。　　一、临床应用　　临床广泛应用克拉维酸钾与青霉素类的复合制剂，如奥格门丁(阿莫西林+克拉维酸钾)，替门汀(替卡西林钠+克拉维酸...